​The department is particularly known for its contribution to pain management of children following surgery, and pain management of children with cancer and blood diseases.​

This function is managed by a pain nurse with specialist training together with a group of experienced physicians.

The department is one out of four anaesthesia and surgery units with an acute function for newborns with congenital abnormalities, children with cancer and blood diseases, as well as young children with general surgical disorders.

The department also provides anaesthetic and surgical services to the following patient groups:

  • Women’s diseases (gynaecology and obsterics)
  • Births
  • Cancer diseases (in children)
  • Blood diseases
  • Paediatric surgery and medical children’s diseases

In addition, the department carries out a number of other assignments such as pain treatment and application of various catheters, necessary in the treatment of patients with cancer diseases.​

Us in numbers

​We are

  • 11 physicians, of whom 6 are in training as specialists in anaesthesiology
  • 19 anaesthesiology nurses
  • 1 pain nurse
  • 2 anaesthesiology nurse course participants
  • 2 nursing aides
  • 35 operating nurses and a secretary

We perform annually

  • Approx. 7,000 anaesthesias in total, divided into:
  • Approx. 2,200 child anaesthesias
  • Approx. 2,300 anaesthesias for gynaecological procedures
  • 1,350 anaesthesias for obstetrical patients, including about 1,200 Caesare​an sections
  • Approx. 1,400 birth epidurals
  • Approx. 700 anaesthesias for oncological gynaecology​​

Application of various central vein catheters, about 1,400/year in total. 

We work in

  • 9 operating theatres

Activities outside the surgical ward include assistance for

  • ​CT scans
  • X-ray examinations
  • Birth epidurals
  • IV access etc.​​

Teaching

​Postgradudate training

Medical specialist training in anaesthesiology
The department carries out extensive postgraduate training activities, with six physicians who are reserved for training of medical specialists in anaesthesiology.

Paediatric Anaesthesia and Intensive Care Medicine (SSAI)
The department also very active in the inter-Nordic Paediatric Anaesthesia and Intensive Care Medicine (SSAI) education. The results accomplished by the department have contributed to the Juliane Marie Centre being approved as provider of the EPLS course (European Paediatric Life Support) in Denmark.​​

Conditions and treatments

The department assists in operation and anaesthesia of: 

  • Children who are primarily admitted for urological and gastrointestinal surgical procedures, congenital abnormalities and haematological/oncologistical diagnostics and treatment of children. 
  • Women who are admitted for gynaecological procedures, particularly ovary cancer and other gynaecological cancer diseases and endometriosis. 
  • Women in labour, women in need of Caesare​an sections and other operations in connection with giving birth.
  • Oncological and haematological patients (children and adults) for application of permanent intravenous access, diagnostics and treatment.
  • Anaesthetic service for the radiotherapy department, the X-ray and clinical physiology department. 
The department has a special Unit for Pain in Children and it works specifically with pain treatment of children and assists in pain-related procedures involving children. Read more about this (in Danish)​​​.
​

​

Mona Tarpgaard
Head of Department, Consultant
Section 4013

Tel: +45 35 45 17 45​
E-mail: mona.tarpgaard@regionh.dk​​




Karin Lornsen Jakobsen
Head Nurse, Section 4013

Tel: +45 35 45 40 13
E-mail: karin.lornsen.jakobsen.01@regionh.dk

Department of Anaesthesiology at the Juliane Marie Centre
Section 4013 & 4014

Entrance 4, 1st floor
Juliane Maries Vej 8
DK-2100 Copenhagen OE
Denmark​

Tel: +45 35 45 40 13
​Fax: +45 35 45 45 25​​

Map​


 News from Rigshospitalet

Danish corona research could improve vaccination techniques

​Ground-breaking research from Copenhagen University Hospital – Rigshospitalet and Herlev and Gentofte Hospital has shed new light on the immune system’s complex struggle against the coronavirus.

Data from olaparib treated patients across histologies presented at Danske Kræftforskningsdage 2023

First surgical 'Nobel Prize' goes to Danish Professor

​​Professor Henrik Kehlet from Copenhagen University Hospital - Rigshospitalet​ recei​ves a new, prestigious award ​in surgery for his lifelong work on patient care and Enhanced Recovery After Surgery(ERAS).

New study: a plant-based diet has an effect on your cholesterol level

​The hitherto largest study to investigate the effect of vegetarian and vegan diets shows that it is possible to reduce ‘bad’ cholesterol levels by up to 14 per cent by eating plant-based foods. A plant-based diet throughout life can reduce the risk of blood clots in the heart considerably.

More cancer patients can escape chemotherapy

​A paradigm shift is on the way in the treatment of chronic lymphatic leukaemia (CLL). From now on, targeted treatment could replace chemotherapy for most of the patients, according to new research.

DNA screening can save lives – new Danish method makes it 20-times cheaper

​Researchers have found the world’s cheapest method of screening large groups of people for rare genetic diseases. The method is now being tested in a large research project with support totalling DKK 36.7 mill. from Innovation Fund Denmark, Børnecancerfonden and the Novo Nordisk Foundation​

Stem cells give cancer patients their saliva back

Many people with cancer suffer damage to their salivary glands as a side effect of radiation therapy. Researchers from Copenhagen University Hospital - Rigshospitalet now hope to be able to restore patients’ saliva function with a promising stem cell treatment.

New project to measure Alzheimer's and Parkinson's via the ear

​Serious brain diseases such as Alzheimer's and Parkinson's are usually diagnosed too late for optimal benefit from available drug and non-drug treatments. A new research project will develop and test a scalable home health care technology that could have a major impact on early detection, diagnosis, prevention and treatment of both diseases.

Presentation at European Lung Cancer Congress

​Martin Højgaard presented data under the title “Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with Larotrectinib” at European Lung Cancer Congress (ELCC)

New germline pathogenic variants identified in mesothelioma patients

​A newly published study revealed a high frequency of germline pathogenic variants in patients with mesothelioma including variants in two genes not previously associated with mesothelioma. The data support germline testing in these patients to identify potential actionable targets and genetic counseling.​​